Contraline-a Blower of trails in the nascent masculine contraceptive released in the promising promising data market on Thursday that show that the company’s contraceptive hydrogel has shown security and effectiveness in the first two participants of the trials to reach two years.
In November 2022, Contraline, based in Virginia, became the first company to implement a male contraceptive gel in humans in a clinical trial. For now, the gel has been implemented in the leg in the Vas Vass of 25 men, and the initial test data look good.
Contraline’s trial is being held in three medical centers in Australia. When he started, CEO Kevin Eisenfrats told him Medcity news The fact that the company’s contraceptive product, called Adam, is sometimes called “diu for men” because it seeks to be a long -standing but reversible birth control method.
That’s where the analogy stops, he thought, because Adam is not hormonal and comes in gel. But similar to a IUD, the gel can be implemented on a quick visit to the doctor’s office.
Using a non -invasive and unparalleled method, the doctor injects the hydrogel into the patient’s deferens. Once the sperm is blocked to travel through Vas Deferens, a man does not produce sperm in his ejaculate and, therefore, cannot fertilize an egg.
The office procedure is performed under local anesthesia and takes less than 20 minutes, said Eisenfrats.
Contraline has been closely watching its trial participants and plans to do it for the next two years, he said. Until now, there are no leg cases of any severe advertising event. Some patients have reported things like bruises or light swelling in the days after their procedure, but the thesis has a soft bone and disappeared quickly, they explained the requirements.
Now that two trial participants have shown a zero sperm count over 24 months, Contraline is checking the duration of its planned products, he added.
“The idea for Adam always has a leg that could be the IUD for men, and all our market research supports something that lasts one or two years. Ideally, men could obtain this procedure every two years. Actuy toaal, data data data data that declared Eisenfrats.
The main objective behind the first in-human trial of Contraline was to demonstrate Adam’s security and determine the optimal amount of hydrogel necessary for maximum efficiency. The company is approved at the beginning of its next test, which will focus on the Adam’s reversibility test in Australia, and is working with the FDA to obtain permission to begin to implement its gel in the US. UU., Said the requirements.
The generation of data that can prove the reversibility of the gel will be the next great milestone of Contraline, he said.
“Reversibility is everything, it is the difference between the product that is an alternative of vasectomy and is the IUD for men, which is something that dozens of millions of men would be interested in using. The fixed marjory whose combinations of combat-compulsion to Coniaria have children in the future or could want children in the future.
The product is reversible in two ways, he said: Natural biodegradation in time or early elimination through a minimally invasive procedure.
Eisenfrats seems to be correct in his statement that Hards of Men is interested in a product like Adam that hits the market. When the company begged the advertising of its Australian essay, intentionally made the length of the application survey and full of detailed questions so that it could take anyone who did not take seriously the desire to prove the gel, Eisenfrats said. Even so, more than 1,500 men complete the application.
The requirements of the Frates noticed that the thesis men came from the life rides of the first 20 years, some were medium age, some were in long -term relationships, some were single, some had no children and some had already become parents.
Contraline is still in conversations with the FDA about the US trials., But the requirements said the company aims to obtain the ADAM approach at the end of 2028. He added that the mayor of Australian approach, depending on the regulatory roads.
Photo: Contraline